skip to main content

New Investigators

This program provides research operating grant support to future leaders as they develop their independent careers in cancer research. Designed to provide a single research grant to scientific and clinical investigators within the first five years of a first faculty-level appointment in Canada, new investigators have to be sponsored and mentored by an existing Terry Fox funded program.

A Request for Applications (RFA) is issued annually.  The deadlines for the 2018 competition will be announced in mid-April, 2017.


A List of Current Terry Fox New Investigators


Name Start/End Project
Housheng Hansen He
2017-2020 Understanding the function of circular RNA in tumour hypoxia
Frederick Antoine Mallette
 Deciphering the oncogenic properties of cancer-associated IDH1/2 mutations
Peter Stirling
Functionalizing SWI/SWF chromatin remodeller mutations in rare and common tumours
Guy Ungerechts
2016-2019 Next Generation Cancer Immunovirotherapy: Heterologous oncolytic prime-boost enhanced with select immunomodulators
Ralph DaCosta
2016-2019 Investigating radiation responses of pancreatic tumours, their vasculature and microenvironment using in vivo imaging to identify new treatment strategies
William Lockwood
2016-2019 Assessing the effect of radiation from screening low dose CT scans on lung cancer development and progression
Byram Bridle
2015-2018 Evaluation of oncolytic immunotherapy in canine cancer trials: A stepping stone towards successful translation into human patients
Sonia Cellot
2015-2017 Deciphering the role of chromatin demethylases in high risk pediatric acute myeloid leukemia
Martin Hirst
2015-2017 Epigenetic basis of acute myeloid leukemia
Ryan Morin
2015-2017 Exploring Clonal Evolution in Non-Hodgkin Lymphomas Using Serial Tumour Sampling and Liquid Biopsies
John Stagg
2015-2017 The role of the CD73 adenosinergic pathway in prostate cancer
Brian Wilhelm
2015-2017 Transcriptional and Epigenetic Consequences of Mll-AF9 Translocations
Francis Rodier
2014-2016 Understanding the Impact of Cancer Cell Fate Decisions during Ovarian Cancer Treatment
Paul Boutros
2013-2016 Systems Biology of Tumour Hypoxia
Catherine O’Brien
2013-2016 Understanding Cancer Stem Cell Heterogeneity and Dynamics: Implications for Therapy in Human Colorectal Cancer
Luke McCaffrey 2011-2015 Epithelial polarity in tumour invasion and metastasis
Rebecca Auer 2012-2015 A Personalized Oncolytic Vaccine: Using Oncolytic Viruses to Exploit Neo-antigens Derived from the Tumour Mutanome
Sohrab Shah 2012-2015 Are Genomic Instability and Clonal Diversity Prognostic Indicators of High Grade Serous Ovarian Cancer?
Gelareh Zadeh 2012-2015 Exploring Novel Mechanisms of Tumor Vascularization in Malignant Brain Tumors


For more information on the above projects, please go to the Canadian Research Information System (CRIS) database.


Back to Top